Patents Assigned to Hetero Research Foundation
  • PHARMACEUTICAL COMPOSITIONS OF ASENAPINE
    Publication number: 20170007537
    Abstract: The present invention relates to liquid compositions of asenapine with one or more pharmaceutically acceptable excipients. More particularly, the present invention relates to liquid spray compositions comprising asenapine for administration through oral mucosa.
    Type: Application
    Filed: February 16, 2015
    Publication date: January 12, 2017
    Applicant: HETERO RESEARCH FOUNDATION
    Inventors: BANDI PARTHASARADHI REDDY, PODILI KHADGAPATHI, PATCHIGOLLA SATYANARAYANA RAO
  • C-3 NOVEL TRITERPENONE WITH C-28 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20170008921
    Abstract: The invention relates to C-3 novel triterpenone with C-28 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: February 9, 2016
    Publication date: January 12, 2017
    Applicant: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Gazula Levi David Krupadanam, Adulla Panduranga Reddy, Kasireddy Bhaskar Reddy, Lanka VL Subrahmanyam
  • Process for fosaprepitant
    Patent number: 9540406
    Abstract: The present invention provides a novel process for reducing palladium content in fosaprepitant dimeglumine.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: January 10, 2017
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Thungathurthy Srinivasa Rao, Bandi Vamsi Krishna
  • Process for Regorafenib
    Patent number: 9518020
    Abstract: The present invention provides processes for the preparation of i) Regorafenib (4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, BAY 73-4506, Stivarga®) and its pharmaceutically acceptable salt thereof; ii) a crystalline solid of Regorafenib tosylate; iii) Regorafenib Polymorph I from Regorafenib tosylate, and iv) a pure 4-(4-amino-3-fluorophenoxy)-N-methylpicolinamide from 4-amino-3-fluorophenol and 4-chloro-N-methylpicolinamide in the presence of potassium tert-butoxide.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: December 13, 2016
    Assignee: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Thungathurthy Srinivasa Rao, Bandi Vamsi Krishna
  • Linagliptin solid dispersion
    Patent number: 9381199
    Abstract: The present invention provides a novel amorphous solid dispersion of linagliptin in combination with a pharmaceutically acceptable carrier, process for its preparation and pharmaceutical compositions comprising it.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: July 5, 2016
    Assignee: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Kesireddy Subash Chander Reddy, Bandi Vamsi Krishna
  • Solid oral compositions of tolvaptan
    Patent number: 9345712
    Abstract: The present invention relates to solid dispersion compositions of tolvaptan and process for the preparation of oral dosage forms.
    Type: Grant
    Filed: October 23, 2013
    Date of Patent: May 24, 2016
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Podili Khadgapathi, Goli Kamalakar Reddy
  • Process for bendamustine hydrochloride
    Patent number: 9273010
    Abstract: The present invention provides a process for the preparation of 1H-benzimidazol-1-methyl-5-N,N-di(2-hydroxyethyl)-2-butanoic acid ethyl ester. The present invention also provides a process for the preparation of bendamustine hydrochloride. The present invention further provides a process for the purification of bendamustine hydrochloride.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: March 1, 2016
    Assignee: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Bandi Vamsi Krishna
  • Rilpivirine hydrochloride
    Patent number: 9233935
    Abstract: The present invention provides a novel process for the preparation of rilpivirine. The present invention also provides a novel process for the preparation of rilpivirine hydrochloride. The present invention further provides a rilpivirine hydrochloride monohydrate, process for its preparation and pharmaceutical compositions comprising it.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: January 12, 2016
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Adulla Venkat Narsimha Reddy, Bandi Vamsi Krishna
  • Crystalline hydrochloride salt of darunavir
    Patent number: 9175005
    Abstract: The present invention provides novel crystalline hydrochloride salt of darunavir, process for its preparation and to pharmaceutical composition comprising it. The present invention also provides novel process for preparation of darunavir amorphous form and pharmaceutical composition comprising it.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: November 3, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Rapolu Raji Reddy, Bandi Vamsi Krishna, Kesireddy Subash Chander Reddy
  • Process for sorafenib tosylate polymorph III
    Patent number: 9156789
    Abstract: The present invention provides a novel process for the preparation of sorafenib tosylate polymorph III.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: October 13, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Thungathurthy Srinivasa Rao, Bandi Vamsi Krishna
  • Process for the preparation of pazopanib using novel intermediate
    Patent number: 9150547
    Abstract: The present invention provides a commercially viable process for preparing pazopanib and its pharmaceutically acceptable acid addition salts thereof in high yields using novel intermediate. The present invention also provides a process for the purification of pazopanib hydrochloride.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: October 6, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Thungathurthy Srinivasa Rao, Bandi Vamsi Krishna
  • Process for rilpivirine using novel intermediate
    Patent number: 9139535
    Abstract: The present invention provides a commercially viable process for preparing rilpivirine and its pharmaceutically acceptable acid addition salts thereof in high yields using novel intermediate.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: September 22, 2015
    Assignee: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Adulla Venkat Narsimha Reddy, Bandi Vamsi Krishna
  • Bioequivalent formulation of efavirenz
    Patent number: 9138412
    Abstract: The present invention provides a suitable technique namely wet milling and the process for reducing the particle size of efavirenz and making a tablet or capsule formulation with desired bioavailability equivalent to the reference listed drug without loosing its characteristics.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: September 22, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Podili Khadgapathi, Goli Kamalakar Reddy
  • Pharmaceutical compositions of linezolid
    Patent number: 9132132
    Abstract: The present invention relates to stable pharmaceutical compositions comprising linezolid crystalline Form III with one or more pharmaceutically acceptable excipients, wherein the composition retains linezolid in its original crystalline form.
    Type: Grant
    Filed: August 29, 2011
    Date of Patent: September 15, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Podili Khadgapathi, Goli Kamalakar Reddy, Lekkala Vamshi Krishna
  • Process for rilpivirine
    Patent number: 9126949
    Abstract: The present invention provides a novel process for the preparation of 4-(4-hydroxypyrimidin-2-ylamino)benzonitrile. The present invention also provides a novel process for the preparation of 4-iodo-2,6-dimethyl benzenamine. The present invention further provides an improved process for the preparation of rilpivirine. The present invention further provides a tosylate salt of rilpivirine, process for its preparation and pharmaceutical compositions comprising it.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: September 8, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Adulla Venkat Narsimha Reddy, Bandi Vamsi Krishna
  • Process for the resolution of omeprazole
    Patent number: 9115118
    Abstract: The present invention relates to process for the resolution of omeprazole. The present invention further provides a novel compound of enantiomers of omeprazole cyclic amine salt and a process for preparing it. The present invention also provides a solid of (R)- or (S)-omeprazole cyclic amine salt and a process for preparing it. The present invention also provides a process for the preparation of esomeprazole magnesium dehydrate substantially free of its trihydrate form. The present invention also provides a process for the preparation of recovery of chiral BINOL.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: August 25, 2015
    Assignee: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Rapolu Raji Reddy, Dasari Muralidhara Reddy, Bandi Vamsi Krishna, Voggu Ramesh Reddy
  • Pharmaceutical Formulations of Rufinamide
    Publication number: 20150224086
    Abstract: The present invention relates to pharmaceutical compositions comprising rufmamide premix and one or more pharmaceutically acceptable excipients and methods of preparing the same.
    Type: Application
    Filed: August 5, 2013
    Publication date: August 13, 2015
    Applicant: Hetero Research Foundation
    Inventors: Bandi Parthasaradhi Reddy, Podili Khadgapathi, Goli Kamalakar Reddy
  • Amorphous ritonavir co-precipitated
    Patent number: 9096556
    Abstract: The present invention relates to amorphous ritonavir co-precipitated on copovidone, process for its preparation and pharmaceutical compositions comprising it.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: August 4, 2015
    Assignee: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Bandi Vamsi Krishna
  • Lupeol-type triterpene derivatives as antivirals
    Patent number: 9067966
    Abstract: The invention relates to novel lupeol-type triterpene derivatives and related compounds, and pharmaceutical compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: June 30, 2015
    Assignee: HETERO RESEARCH FOUNDATION, HETERO DRUGS LTD.
    Inventors: Bandi Parthasaradhi Reddy, Vedula Manohar Sharma, Kura Rathnakar Reddy, Musku Madhanmohan Reddy, Nelli Yella Reddy, Lanka VL Subrahmanyam
  • PROCESS FOR SORAFENIB TOSYLATE POLYMORPH III
    Publication number: 20150133670
    Abstract: The present invention provides a novel process for the preparation of sorafenib tosylate polymorph III.
    Type: Application
    Filed: May 21, 2013
    Publication date: May 14, 2015
    Applicant: HETERO RESEARCH FOUNDATION
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Dasari Muralidhara Reddy, Thungathurthy Srinivasa Rao, Bandi Vamsi Krishna